AlveoliX AG, Switzerland
AlveoliX is developing advanced in vitro models to change the classical drug development. We aim to make organs-on-chip the leading alternative to animal experiments and a new standard for preclinical decision-making.
AlveoliX’s Barrier-on-Chip System allows to reproduce the microenvironment of human organs in an unprecedented way. The possibility of applying cyclic stretch to our ultrathin membrane stimulates the cells, keeping them functional and in a physiological shape. With our technology, we can recreate healthy, diseased, and personalized in-vitro models to test molecule safety and toxicity (drugs, pollutants, cosmetics, etc.) as well as to answer fundamental research questions.
Role in the Project: Hosting secondments